知镜 Cognispect · 医学文献与研究工作台

Association of the new atherogenic index non-high-sensitivity C-reactive protein/HDL with significant coronary artery disease in patients with suspected coronary artery disease.

Vallejo-Garcia V, Fabregat-Ándres Ó, Ferrer Sargues FJ, Valtueña-Gimeno N, Cejalvo-Lapeña D, Valls Gumbau G, Tormos JM.
Revista clinica espanola · 2026-11-05 · PMID 42988042

文献摘要

Introduction Atherosclerosis is the main cause of coronary heart disease (CHD). Atherogenic indexes (AI) are used to stratify cardiovascular risk. The aim of this study is to evaluate the association with significant CHD of a novel AI that includes parameters of both inflammatory residual risk and lipidic residual risk. Methods 203 patients with suspicion of coronary heart disease were included. The new AI was established as the ratio between CRP (mg/dL) multiplied by 100, and HDL-C (mg/dL). It was compared with traditional AI Castelli I and II, and atherogenic index of plasma (AIP). Results The mean age was 53.9 ± 7.34 years. 114 patients (55.9%) had significant CHD. The ratio PCRx100/HDL had the highest values of sensibility and specifity and was the only predictor of CHD with OR 1.59 (CI 95% 1.2-2.1, p = 0.001) and multivessel disease with OR of 1.45 (CI 95% 1.2-1.7, p Conclusions The new ratio PCRx100/HDL shows the best association with significant CHD.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。